Molecular Biology

C.F. Lesser, C. Guthrie,"Mutations in U6 snRNA that alter splice-site specificity--implications for the active site," Science, 262:1982-88, 1993. Cammie Lesser (Department of Biochemistry and Biophysics, School of Medicine, University of California, San Francisco): "Nuclear pre-mRNA splicing is the process by which the introns- -the noncoding portions of precursor mRNAs--are removed and the coding sequences called exons are ligated

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Cammie Lesser (Department of Biochemistry and Biophysics, School of Medicine, University of California, San Francisco): "Nuclear pre-mRNA splicing is the process by which the introns- -the noncoding portions of precursor mRNAs--are removed and the coding sequences called exons are ligated together. This process is mediated by the spliceosome, a cellular complex composed of both RNA and proteins. A major challenge has been determining how the components of the spliceosome identify the exact intron/exon boundaries (splice-sites) and then juxtapose the catalytic residues of the spliceosome with these boundaries. The information content at the splice sites is very limited, because there is a serious problem in maintaining the fidelity of the reaction.

"Early studies demonstrated that one of the RNAs--the small nuclear RNA (snRNA) U1--base-pairs with the 5_ splice site. This RNA-RNA interaction is important for recognizing and committing the pre-mRNA to the splicing pathway. However, it is not sufficient to determine ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies